Those  implementing  acts  shall  be  adopted  in  accordance with the examination procedure referred to in Article 114(3).
- 3. The Commission shall ensure that Member States share expertise in the fields of medical devices, in  vitro diagnostic medical devices, medicinal products, human tissues and cells, cosmetics, biocides, food and, if necessary, other  products, in order  to determine the appropriate regulatory status of a product, or category or group of products.
- 4. When deliberating  on  the  possible  regulatory  status  as  a  device  of  products  involving  medicinal  products,  human tissues  and  cells,  biocides  or  food  products,  the  Commission  shall  ensure  an  appropriate  level  of  consultation  of  the European Medicines Agency (EMA), the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA), as relevant.
## CHAPTER II
## MAKING  AVAILABLE  ON  THE  MARKET  AND  PUTTING  INTO  SERVICE  OF  DEVICES,  OBLIGATIONS  OF ECONOMIC OPERATORS, REPROCESSING, CE MARKING, FREE MOVEMENT
Article 5
## Placing on the market and putting into service
- 1. A  device  may  be  placed  on  the  market  or  put  into  service  only  if  it  complies  with  this  Regulation  when  duly supplied and properly installed, maintained and used in accordance with its intended purpose.
- 2. A device  shall  meet  the  general  safety  and  performance  requirements  set  out  in  Annex  I  which  apply  to  it,  taking into account its intended purpose.
